Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Am J Physiol Renal Physiol ; 296(1): F54-9, 2009 Jan.
Article in English | MEDLINE | ID: mdl-18829741

ABSTRACT

It is well known that Glucagon (Gl) is released after a high protein diet and participates in water excretion by the kidney, principally after a protein meal. To study this effect in in vitro perfused inner medullary collecting ducts (IMCD), the osmotic water permeability (Pf; mum/s) at 37 degrees C and pH 7.4 in normal rat IMCDs (n = 36) perfused with Ringer/HCO(3) was determined. Gl (10(-7) M) in absence of Vasopressin (AVP) enhanced the Pf from 4.38 +/- 1.40 to 11.16 +/- 1.44 microm/s (P < 0.01). Adding 10(-8), 10(-7), and 10(-6) M Gl, the Pf responded in a dose-dependent manner. The protein kinase A inhibitor H8 blocked the Gl effect. The specific Gl inhibitor, des-His(1)-[Glu(9)] glucagon (10(-7) M), blocked the Gl-stimulated Pf but not the AVP-stimulated Pf. There occurred a partial additional effect between Gl and AVP. The cAMP level was enhanced from the control 1.24 +/- 0.39 to 59.70 +/- 15.18 fm/mg prot after Gl 10(-7) M in an IMCD cell suspension. The immunoblotting studies indicated an increase in AQP2 protein abundance of 27% (cont 100.0 +/- 3.9 vs. Gl 127.53; P = 0.0035) in membrane fractions extracted from IMCD tubule suspension, incubated with 10(-6) M Gl. Our data showed that 1) Gl increased water absorption in a dose-dependent manner; 2) the anti-Gl blocked the action of Gl but not the action of AVP; 3) Gl stimulated the cAMP generation; 4) Gl increased the AQP2 water channel protein expression, leading us to conclude that Gl controls water absorption by utilizing a Gl receptor, rather than a AVP receptor, increasing the AQP2 protein expression.


Subject(s)
Aquaporin 2/metabolism , Glucagon/physiology , Kidney Medulla/metabolism , Kidney Tubules, Collecting/metabolism , Animals , Cyclic AMP/metabolism , Dose-Response Relationship, Drug , Glucagon/antagonists & inhibitors , Glucagon/metabolism , Isoquinolines/pharmacology , Kidney Medulla/cytology , Kidney Tubules, Collecting/cytology , Male , Osmosis , Rats , Rats, Wistar , Vasopressins/pharmacology
2.
Pflugers Arch ; 456(6): 1229-37, 2008 Sep.
Article in English | MEDLINE | ID: mdl-18449563

ABSTRACT

It is well-known that glucagon increases fractional excretion of urea in rats after a protein intravenous infusion. This effect was investigated by using: (a) in vitro microperfusion technique to measure [(14)C]-urea permeability (Pu x 10(-5)cm/s) in inner medullary collecting ducts (IMCD) from normal rats in the presence of 10(-7)M of glucagon and in the absence of vasopressin and (b) immunoblot techniques to determine urea transporter expression in tubule suspension incubated with the same glucagon concentration. Seven groups of IMCDs (n = 47) were studied. Our results revealed that: (a) glucagon decreased urea reabsorption dose-dependently; (b) the glucagon antagonist des-His(1)-[Glu(9)], blocked the glucagon action but not vasopressin action; (c) the phorbol myristate acetate, decreased urea reabsorption but (d) staurosporin, restored its effect; e) staurosporin decreased glucagon action, and finally, (f) glucagon decreased UT-A1 expression. We can conclude that glucagon reduces UT-A1 expression via a glucagon receptor by stimulating PKC.


Subject(s)
Glucagon/pharmacology , Kidney Tubules, Collecting/metabolism , Membrane Transport Proteins/biosynthesis , Protein Kinase C/biosynthesis , Animals , Blotting, Western , Cell Membrane/drug effects , Cell Membrane/enzymology , Down-Regulation/drug effects , Electrophoresis , Kidney/drug effects , Kidney/metabolism , Kidney Tubules, Collecting/drug effects , Male , Membrane Transport Proteins/genetics , Perfusion , Rats , Rats, Wistar , Urea Transporters
3.
Am J Physiol Renal Physiol ; 292(2): F586-92, 2007 Feb.
Article in English | MEDLINE | ID: mdl-16940563

ABSTRACT

Leptospirosis is a public health problem worldwide. Severe leptospirosis manifests as pulmonary edema leading to acute respiratory distress syndrome and polyuric acute renal failure (ARF). The etiology of leptospirosis-induced pulmonary edema is unclear. Lung edema clearance is largely affected by active sodium transport out of the alveoli rather than by reversal of the Starling forces. The objective of this study was to profile leptospirosis-induced ARF and pulmonary edema. We inoculated hamsters with leptospires and collected 24-h urine samples on postinoculation day 4. On day 5, the animals were killed, whole blood was collected, and the kidneys and lungs were removed. Immunoblotting was used to determine expression and abundance of water and sodium transporters. Leptospirosis-induced ARF resulted in natriuresis, lower creatinine clearance, and impaired urinary concentrating ability. Renal expression of the sodium/hydrogen exchanger isoform 3 and of aquaporin 2 was lower in infected animals, whereas that of the Na-K-2Cl cotransporter NKCC2 was higher. Leptospirosis-induced lesions, predominantly in the proximal tubule, were responsible for the polyuria and natriuresis observed. The polyuria might also be attributed to reduced aquaporin 2 expression and the attendant urinary concentrating defect. In the lungs, expression of the epithelial sodium channel was lower, and NKCC1 expression was upregulated. We found that leptospirosis profoundly influences the sodium transport capacity of alveolar epithelial cells and that impaired pulmonary fluid handling can impair pulmonary function, increasing the chance of lung injury. Greater knowledge regarding sodium transporter dysregulation in the lungs and kidneys can provide new perspectives on leptospirosis treatment.


Subject(s)
Aquaporin 2/metabolism , Epithelial Sodium Channels/biosynthesis , Kidney/physiopathology , Leptospirosis/physiopathology , Lung/physiopathology , Sodium-Hydrogen Exchangers/metabolism , Sodium-Potassium-Exchanging ATPase/biosynthesis , Acute Kidney Injury/physiopathology , Animals , Aquaporin 2/biosynthesis , Blotting, Western , Cricetinae , Pulmonary Edema/physiopathology , Sodium-Potassium-Chloride Symporters/biosynthesis , Solute Carrier Family 12, Member 1 , Solute Carrier Family 12, Member 2 , Up-Regulation
4.
J Am Soc Nephrol ; 16(11): 3339-49, 2005 Nov.
Article in English | MEDLINE | ID: mdl-16177005

ABSTRACT

Magnesium is a potent vasodilator whose effects have not been evaluated in renal ischemia. The antioxidant properties of N-acetylcysteine (NAC) partially protect animals from ischemic/reperfusion injury. This study was designed to evaluate magnesium supplementation, alone or combined with NAC, on ischemic acute renal failure. Rats were maintained on normal diets, supplemented or not with MgCl(2).6H(2)O (1% in drinking water) for 23 d, and some rats received NAC (440 mg/kg body wt) on days 20 to 23. On day 21, ischemia was induced by clamping both renal arteries for 30 min. Five groups were studied: Normal, ischemia, ischemia+magnesium, ischemia+NAC, and ischemia+magnesium+NAC. GFR (inulin clearance), renal blood flow (RBF), FEH(2)O, and FENa were determined. Serum magnesium was decreased in ischemia-only rats. Magnesium prevented postischemia GFR and RBF decreases but did not protect against tubular damage. However, NAC completely restored the tubular damage induced by ischemia/reperfusion. Semiquantitative immunoblotting showed that NAC prevented the decreased expression of Na-K-2Cl co-transporter and aquaporin 2 after renal ischemia/reperfusion. Untreated rats with acute renal failure demonstrated markedly decreased endothelial nitric oxide synthase expression. Significantly, treatment with NAC, magnesium, or both completely inhibited downregulation of endothelial nitric oxide synthase. The tubular necrosis scores were lower in rats that were treated with NAC alone or with the magnesium-NAC combination. Magnesium prevented postischemia GFR and RBF decreases but did not protect against tubular damage. The NAC protected tubules from ischemia, decreased infiltrating macrophages/lymphocytes, and had a mild protective effect on GFR. In ischemic/reperfusion injury, renal function benefits more from the magnesium-NAC combination than from magnesium alone.


Subject(s)
Acetylcysteine/therapeutic use , Acute Kidney Injury/prevention & control , Dietary Supplements , Magnesium Chloride/therapeutic use , Renal Circulation/physiology , Acetylcysteine/administration & dosage , Animals , Blood Flow Velocity/drug effects , Cell Membrane/drug effects , Cell Membrane/metabolism , Disease Models, Animal , Glomerular Filtration Rate/drug effects , Ischemia/prevention & control , Kidney/blood supply , Kidney/drug effects , Kidney/pathology , Kidney/physiology , Magnesium Chloride/administration & dosage , Male , Nitric Oxide Synthase Type III/metabolism , Rats , Rats, Wistar , Renal Circulation/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL